Target intelligence / Profile preview

GRHL2 divergent transcript (GRHL2-DT)

Target
GRHL2-DT
Molecular classification
Other (Long non-coding RNA, lncRNA)
01

Overview

GRHL2 divergent transcript (GRHL2-DT, BX357664) is a long non-coding RNA (lncRNA) located on chromosome 8 close to the GRHL2 gene[1]. It is distinguished from GRHL2, which encodes a protein transcription factor implicated in epithelial cell differentiation and several cancers[2][3][4]. There is currently little published evidence describing specific biological function, disease associations, or clinical relevance for GRHL2-DT. Most available literature and molecular studies refer to the protein-coding GRHL2, suggesting that any reference to GRHL2-DT as a protein, receptor, or drug target is likely to be a misattribution. If the intended target is the protein-coding transcription factor "Grainyhead-like protein 2" (GRHL2), which is an established regulator of epithelial biology and a well-characterized cancer-related transcription factor, that is a different molecule and should be distinctly referenced. "GRHL2 divergent transcript" or "GRHL2-DT" is not a receptor, not a protein, and is not currently classified as a conventional drug target. Most described molecular and clinical roles belong to GRHL2 itself, not GRHL2-DT[2][3][4][5].

Other names
BX357664GRHL2-DT
02

Biological functions

Unknown or not well established for GRHL2-DT
03

Disease associations

Other (unknown or uncharacterized for GRHL2-DT)

Beyond the preview

Go deeper on GRHL2 divergent transcript (GRHL2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRHL2 divergent transcript (GRHL2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call